Butasal-100
General data
Product class:
Authorized package
Medicinal product class:
Veterinary medicine
Package code:
1814150
Name of medicinal product:
Butasal-100
Active substances:
Butafosfan+Cyanocobalamin
Estonian
,
English
,
Latin
ATC code:
QA12CX92
Dosage form:
solution for injection
Route of administration:
intramuscular use; subcutaneous use; intravenous use
Strengh:
100mg+0,05mg 1ml
Amount in package:
100ml 6TK
Legal status for supply*:
Subject to medicinal prescription
Class of active substance:
Additional information:
Indication:
As supportive treatment of metabolic or reproductive disorders. In case of peri-parturient metabolic disorders, tetany and paresis (milk fever), the product should be administered in addition to magnesium and calcium, respectively.
Safety features:
No
Summary of product characteristics (SPC):
(last updated 07 May 2021)
Package information leaflet (PIL):
EST
(last updated 07 May 2021)
Labelling:
(last updated 07 May 2021)
Withdrawal time:
Veis, hobune Lihale ja söödavatele kudedele: 0 päeva. Piimale: 0 tundi.
Species:
hobune, koer, veis, kass
Last imported to Estonia:
31 December 2022
Marketing authorization
Marketing authorization holder:
Interchemie Werken De Adelaar Eesti aktsiaselts
Marketing authorization number:
2233
Marketing authorization issued on:
05 May 2020
Marketing authorization expires on:
05 May 2025
Marketing authorization procedure type:
Mutual recognition
Entry/Changing date: 21 January 2022
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription